Iranian Journal of Pediatrics

Published by: Kowsar

A Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus reuteri for Chronic Functional Abdominal Pain in Children

Kambiz Eftekhari 1 , * , Zahra Vahedi 2 , Mojtaba Kamali Aghdam 2 and Diana Noemi Diaz 2
Authors Information
1 Department of Pediatrics, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Pediatrics, Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, IR Iran
Article information
  • Iranian Journal of Pediatrics: December 28, 2015, 25 (6); e2616
  • Published Online: December 23, 2015
  • Article Type: Research Article
  • Received: May 30, 2015
  • Revised: August 11, 2015
  • Accepted: August 22, 2015
  • DOI: 10.5812/ijp.2616

To Cite: Eftekhari K, Vahedi Z, Kamali Aghdam M, Noemi Diaz D. A Randomized Double-Blind Placebo-Controlled Trial of Lactobacillus reuteri for Chronic Functional Abdominal Pain in Children, Iran J Pediatr. 2015 ;25(6):e2616. doi: 10.5812/ijp.2616.

Abstract
Copyright © 2015, Growth & Development Research Center.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
2. Objectives
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Sreedharan R, Chris A. Nelson Text Book of Pediatrics. 2011; : 1643-6
  • 2. Helgeland H, Flagstad G, Grøtta J, Vandvik P, Kristensen H, Markestad T. Diagnosing Pediatric Functional Abdominal Pain in Children (4–15 Years Old) According to the Rome III Criteria: Results From a Norwegian Prospective Study. J Pediatr Gastroenterol Nutr. 2009; 49(3): 309-15[DOI]
  • 3. Perquin CW, Hunfeld JA, Hazebroek-Kampschreur AA, Suijlekom-Smit LW, Passchier J, Koes BW, et al. The natural course of chronic benign pain in childhood and adolescence: a two-year population-based follow-up study. Eur J Pain. 2003; 7(6): 551-9[DOI]
  • 4. Achenbach TM, McConaughy SH, Howell CT. Child/adolescent behavioral and emotional problems: implications of cross-informant correlations for situational specificity. Psychol Bull. 1987; 101(2): 213-32[PubMed]
  • 5. Farahmand F, Modaresi V, Najafi M, Khodadad A, Moetamed F, Modarres Z. Prevalence of celiac disease in Iranian children with recurrent abdominal pain referred to a pediatric referral center. Iran J Pediatr. 2011; 21(1): 33-8[PubMed]
  • 6. Jee SR, Jung HK, Min BH, Choi KD, Rhee PL, Kang YW, et al. [Guidelines for the treatment of functional dyspepsia]. Korean J Gastroenterol. 2011; 57(2): 67-81[PubMed]
  • 7. Korterink JJ, Ockeloen L, Benninga MA, Tabbers MM, Hilbink M, Deckers-Kocken JM. Probiotics for childhood functional gastrointestinal disorders: a systematic review and meta-analysis. Acta Paediatr. 2014; 103(4): 365-72[DOI][PubMed]
  • 8. Szajewska H. Walker's Pediatric Gastrointestinal Disease. 2008; : 399-409
  • 9. Jafari E, Vahedi H, Merat S, Momtahen S, Riahi A. Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating. Arch Iran Med. 2014; 17(7): 466-70[PubMed]
  • 10. Horvath A, Szajewska H. Probiotics, prebiotics, and dietary fiber in the management of functional gastrointestinal disorders. World Rev Nutr Diet. 2013; 108: 40-8[DOI][PubMed]
  • 11. Demers M, Dagnault A, Desjardins J. A randomized double-blind controlled trial: Impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin Nutr. 2014; 33(5): 761-7[DOI]
  • 12. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther. 2011; 33(12): 1302-10[DOI][PubMed]
  • 13. Bieri D, Reeve RA, Champion DG, Addicoat L, Ziegler JB. The faces pain scale for the self-assessment of the severity of pain experienced by children: Development, initial validation, and preliminary investigation for ratio scale properties. Pain. 1990; 41(2): 139-50[DOI]
  • 14. Saps M, Lu P, Bonilla S. Cow's-milk allergy is a risk factor for the development of FGIDs in children. J Pediatr Gastroenterol Nutr. 2011; 52(2): 166-9[DOI][PubMed]
  • 15. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010; 59(5): 605-11[DOI][PubMed]
  • 16. Wilhelm SM, Brubaker CM, Varcak EA, Kale-Pradhan PB. Effectiveness of probiotics in the treatment of irritable bowel syndrome. Pharmacotherapy. 2008; 28(4): 496-505[DOI][PubMed]
  • 17. Niv E, Naftali T, Hallak R, Vaisman N. The efficacy of <italic>Lactobacillus reuteri</italic> ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study. Clin Nutr. 2005; 24(6): 925-31[DOI][PubMed]
  • 18. Romano C, Ferrau V, Cavataio F, Iacono G, Spina M, Lionetti E, et al. <italic>Lactobacillus reuteri</italic>in children with functional abdominal pain (FAP). J Paediatr Child Health. 2014; 50(10)-71[DOI]
  • 19. Gawronska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther. 2007; 25(2): 177-84[DOI][PubMed]
  • 20. Design of Treatment Trials C, Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006; 130(5): 1538-51[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments